Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Biotech Fund

+ Add to Watchlist

FRABIOZ:LN

326.40 GBp 1.20 0.37%

As of 00:59:30 ET on 05/22/2015.

Snapshot for AXA Framlington Biotech Fund (FRABIOZ)

Year To Date: +20.13% 3-Month: +8.91% 3-Year: +45.77% 52-Week Range: 185.63 - 341.70
1-Month: -1.33% 1-Year: +79.52% 5-Year: - Beta vs NBI: 0.99

Mutual Fund Chart for FRABIOZ

No chart data available.
  • FRABIOZ:LN 326.40
  • 1M
  • 1Y
Interactive FRABIOZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FRABIOZ

AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.

Inception Date: 04-16-2012 Telephone: 44-207-374-4100
Managers: LINDEN THOMSON
Web Site: www.axa-framlington.com

Fundamentals for FRABIOZ

NAV (on 2015-05-22) 326.40
Assets (M) (on 2015-05-21) 728.51
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment 5,000.00

Dividends for FRABIOZ

Dividend Type Accumulation
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for FRABIOZ

Front Load 0.00
Back Load -
Current Mgmt Fee 0.75
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for FRABIOZ

Filing Date: 04/30/2015
Name Position Value % of Total
Gilead Sciences Inc 1,034,764 67,825,800 9.800%
Biogen Inc 244,080 59,520,600 8.600%
Amgen Inc 567,322 58,136,400 8.400%
Celgene Corp 785,687 55,368,000 8.000%
Illumina Inc 270,716 32,528,700 4.700%
Vertex Pharmaceuticals Inc 395,995 31,836,600 4.600%
Regeneron Pharmaceuticals Inc 97,436 29,068,200 4.200%
Incyte Corp 382,300 24,223,500 3.500%
Alexion Pharmaceuticals Inc 213,219 23,531,400 3.400%
BioMarin Pharmaceutical Inc 322,026 23,531,400 3.400%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil